Linked Data API

Show Search Form

Search Results

1003830
registered interest false more like this
date less than 2018-11-09more like thismore than 2018-11-09
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading AAT Deficiency more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of treatments available through the NHS for Alpha-1 Antitrypsin Deficiency. more like this
tabling member constituency Coventry South more like this
tabling member printed
Mr Jim Cunningham more like this
uin 189546 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-11-14more like thismore than 2018-11-14
answer text <p>The National Institute for Health and Care Excellence (NICE) does not currently recommend any specific treatment for Alpha-1 Antitrypsin Deficiency (AATD).</p><p> </p><p>NHS England is engaging with NICE on the Highly Specialised Technologies evaluation of human alpha1-proteinase inhibitor for treating emphysema in adults with documented severe AATD (ID856). NICE has not yet published final guidance and recently consulted on its draft guidance.</p><p> </p><p>NICE’s evaluation committee is due to meet again to consider its recommendations in due course.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
remove filter
answering member
4067
label Biography information for Steve Brine more like this
tabling member
308
label Biography information for Mr Jim Cunningham more like this